Reposal

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Reposal
Reposal.svg
Clinical data
ATC code N05CA12 (WHO)
Identifiers
Synonyms Reposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid
CAS Number 3625-25-0 N
PubChem (CID) 19254
ChemSpider 10468690 YesY
ChEMBL CHEMBL505851 N
Chemical and physical data
Formula C14H18N2O3
Molar mass 262.304 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.[1][2][3]

References[edit]

  1. ^ Kessing, S. V.; Tarding, F.; Thomsen, A. C. (1963). "Reposal, A New Hypnotic. I. Pharmacodynamic Activity". Ugeskrift for laeger (in Danish). 125: 1735–1738. PMID 14103836. 
  2. ^ Kessing, S. V.; Tarding, F.; Thomsen, A. C. (1963). "Reposal, A New Hypnotic. II. Clinical Effects". Ugeskrift for laeger (in Danish). 125: 1739–1741. PMID 14103837. 
  3. ^ Nielsen, P.; Tarding, F. (1968). "The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal)". Acta pharmacologica et toxicologica. 26 (6): 521–530. doi:10.1111/j.1600-0773.1968.tb00471.x. PMID 5756387.